Issues related to independent pharmacy, pharmacy benefit manager practices, prescription drug access and affordability, pharmacy networks, reimbursement, contract terms, patient steering, spread pricing, direct and indirect remuneration fees, rebate and fee transparency, audit rights, claims data transparency, vertical integration, affiliated pharmacy arrangements, mail-order and specialty pharmacy practices, any-willing-pharmacy protections, network adequacy, pharmacy access standards, and policies affecting family-owned and community pharmacies in the commercial market.
2026 · 2nd Quarter (Apr 1 - June 30)
AMERICAN PHARMACIES, INC.
Filed by ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC).
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 16, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)
- Filing UUID
- 7bd0f1d6-4b6e-4ef1-8da3-e74a94da728e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to independent pharmacy in Medicare, Medicaid, and other federal health programs, including Medicare Part D pharmacy access and reimbursement, Medicaid managed care pharmacy reimbursement, PBM spread pricing, direct and indirect remuneration fees, rebate and fee pass-through, pharmacy network adequacy, preferred pharmacy networks, patient steering, mail-order and specialty pharmacy practices, vertical integration, affiliated pharmacy arrangements, essential retail pharmacy access, any-willing-pharmacy protections, long-term care pharmacy access, pharmacist-provided services, Medicare drug pricing implementation, and policies affecting beneficiary access to community pharmacies.
Issues related to the TRICARE pharmacy program; NDAA reauthorization.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.